Lametec 50 DT

Tablet

Epilepsy (partial and generalized seizures, including Lennox–Gastaut syndrome), Bipolar disorder (maintenance treatment to prevent mood episodes)

Lamotrigine is an antiepileptic medicine that stabilizes neuronal membranes by blocking voltage-gated sodium channels. This reduces excessive release of excitatory neurotransmitters (e.g., glutamate) and helps control seizures and mood swings.

Dispersible tablet: take exactly as prescribed. It may be dispersed in a small amount of water and swallowed immediately, or swallowed whole with water. Can be taken with or without food. Dose is usually started low and increased gradually; do not stop suddenly without medical advice.

Dizziness, headache, nausea, vomiting, sleepiness, insomnia, blurred/double vision, tremor, rash

Serious skin reactions (SJS/TEN) can occur, especially in the first 2–8 weeks or with rapid dose escalation; stop and seek urgent care if rash, blistering, mouth sores, fever or facial swelling occurs. Risk increases with valproate co-use. Monitor for suicidal thoughts/behavior and mood changes. Do not discontinue abruptly (may worsen seizures). Use caution in liver or kidney disease. May cause dizziness/blurred vision—avoid driving if affected.

Valproate (increases lamotrigine levels—requires lower dose/titration), enzyme inducers like carbamazepine/phenytoin/phenobarbital/primidone/rifampicin (decrease levels—may need higher dose), combined oral contraceptives containing ethinyl estradiol (can lower lamotrigine levels; lamotrigine may affect contraceptive hormone levels), sertraline and other CNS-acting drugs (additive dizziness/somnolence)

Store below 25°C, in original pack, protected from moisture and light. Keep out of reach of children.

Lamictal 50 DT, Lametor DT 50, Lamogard DT 50, Lamotrigine 50 DT (generic)